CELL Series

Lung cancer is the leading cause of cancer death, but we have the opportunity to reduce late-stage diagnosis and reduce mortality through screening. Join us as we review the importance of a lung screening program and the toolkit NCC's Lung Cancer Collaborative developed to help get your lung screening program off the ground.

Featuring:

Lily Helzer, MPH, Cancer Prevention & Early Detection Programs Manager, Nevada Cancer Coalition

Jamie Studts, PhD, Professor of Medical Oncology, University of Colorado School of Medicine and Co-Leader of Cancer Prevention and Control, University of Colorado Cancer Center

HPV-related head and neck cancers are quickly becoming the leading HPV-related cancer diagnosed in the U.S. Dentists and dental hygienists are often the first to discover these head and neck cancers during routine care. You have the power to reduce the incidence of HPV-related cancers and pre-cancers. The HPV vaccine is nearly 100% effective in preventing all HPV- related cancers, including head and neck cancers. Join us to explore how the dental community can prevent cancer.

Featuring:

Lily Helzer, MPH, Cancer Prevention & Early Detection Programs Manager, Nevada Cancer Coalition

Todd Landaburu, Cancer Survivor

Alice P. Chen, DMD, FAAPD
Roseman University of Health Sciences College of Dental Medicine
Associate Professor and Board Certified Pediatric Dentist

Civon Gewelber, DDS, MHA
Roseman University of Health Sciences College of Dental Medicine
Assistant Professor

Identifying biomarkers in a patient’s tumor tissue or blood is an essential step in developing a personalized treatment plan, which might include targeted medicines or immunotherapies. However, not all patients receive biomarker testing, or tests for all possible biomarkers. There are multiple reasons for today’s biomarker testing gaps, including lack of awareness, inadequate insurance coverage, and practical challenges such as long turn-around times for results. Learn more about biomarkers and biomarker testing in this fast-paced introduction session.

Featuring:

Carol Fier, MSN Principal Medical Science Liaison, Lung, GU and Derm Oncology, US Medical Affairs, Genentech

Emily Driver, PhD Senior Medical Science Liaison, Breast, GI, & Gynecological Oncology, US Medical Affairs, Genentech

Mary Halloran, PharmD, BCPS Principal Medical Science Liaison, Malignant Hematology, US Medical Affairs, Genentech

When caught early, skin cancer is highly treatable. But what do you even look for? Join us for a discussion about knowing your normal,  what changes indicate you need to look deeper, and how skin cancer impacts every skin tone. This presentation is for anyone interested in learning more about skin- for themselves, their families, their patients, and their communities. 

Featuring Dr. Whitney Hovenic.

Hovenic is a Double Board-Certified Dermatologist and Mohs Micrographic Dermatologic Surgeon with Skin Cancer and Dermatology Institute. She is happy to be back in Northern Nevada. A native of California, she graduated from the University of Nevada School of Medicine and completed her residency in dermatology at the University of Missouri. She practiced general dermatology at the University of Missouri before completing a fellowship in Mohs Micrographic Surgery and receiving extensive training in lasers and cosmetic dermatology at the University of California, Irvine. She is a community champion for skin cancer prevention and early detection and the force behind the Biggest Little Skin Cancer Screening to be hosted in Reno on May 7. Participants of this webinar are invited to also volunteer for the Biggest Little Skin Cancer Screening for additional learning experience.

Cancer patients have been suffering in silence when it comes to sexual health issues after treatment. They are in need of anticipatory guidance, but the topic of sexual health is seldom addressed. In this session you'll get a taste of how to prioritize sexual health in oncology care and improve the quality of life for all those affected by cancer, from diagnosis through survivorship. This is the first step to help you normalize the conversation, set patient expectations, and refer patients timely.

This CELL Series session is a preview for a workshop planned for the Nevada Cancer Control Summit Aug. 23-24 in Reno. Attendees of this session will receive priority access to the longer workshop, which has limited space. We will add an additional workshop based on demand.

Featuring:

Amy Thompson, RN, OCN, CN-BN, Survivorship Programs Manager, Nevada Cancer Coalition

Erin Sullivan Wagner, Executive Director of After Cancer, Inc.

In today’s technology-based society, it is easy to get misinformation or misinterpret nutrition guidelines. In this session, you will discover the latest evidenced-based recommendations for cancer prevention and survivorship. We will discuss actionable behavior modifications to reduce the risk for all cancers, while helping to identify resources online to assist with education and support groups for nutrition and physical activity.

Featuring: Karen Fisicaro, RD, LD, CSO, Clinical Dietitian/Nutrition Care Coordinator, Board Certified Specialist in Oncology Nutrition, Carson Tahoe Cancer Center

A first-ever survey conducted by Huntsman Cancer Institute at the University of Utah researchers reveals that residents in frontier areas of the Mountain West face significant barriers to health care. The Community Health Assessment Survey (CHAS) is the first of its kind to focus solely on patients in rural and frontier areas. Rural counties have fewer than 100 people per square mile while frontier areas have seven or fewer per square mile. The team, led by Tracy Onega, PhD, senior director of population sciences at Huntsman Cancer Institute, and professor of population sciences, found that most people living in rural and frontier counties know little to nothing about cancer clinical trials, considered to be the standard of cancer care by the American Society for Clinical Oncology.

Learn more about what the CHAS revealed, including Nevada-specific data, from Huntsman Cancer Institute's Bailee Daniels, MS, CCRC, a senior manager for Population Sciences and Community Outreach & Engagement.

Cancer registries are vital parts of the cancer control and research worlds, providing invaluable data on cancer cases for every state. Join us to learn more about how the Nevada Central Cancer Registry collects and reports data, the role healthcare providers play in cancer data, electronic reporting, and how to request Nevada’s data.

Featuring:

Patience Gbafa, MPH,
Cancer Epidemiologist
Nevada Central Cancer Registry

Aundrea Ogushi
Manager
Nevada Central Cancer Registry

Register here.